MedTech
HeartFlow Shares Surge 47% After $317M Nasdaq IPO
HeartFlow has made a spectacular public market debut, with shares soaring 47% following the company’s $317 million initial public offering on Nasdaq. The strong market
HeartFlow has made a spectacular public market debut, with shares soaring 47% following the company’s $317 million initial public offering on Nasdaq. The strong market
A striking disconnect has emerged in healthcare’s artificial intelligence adoption, with new survey data revealing that while 99% of healthcare organizations are actively using generative
The digital health sector is experiencing a notable resurgence, with U.S. startups raising $6.4 billion in the first half of 2025, marking a modest but
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has unveiled an innovative Early Access program that will allow certain high-priority medical devices to enter
The Ruling’s Ripple Effect for SDK-Based Data Harvesting in Digital Health A landmark court ruling finding Meta liable for improperly collecting sensitive reproductive health data
Implications for Future Pandemic Readiness and Platform Vaccine Funding The Department of Health and Human Services’ decision to terminate multiple pandemic-era mRNA vaccine development programs
How Upcoming Tariffs Could Reshape Drug Pricing, Global Manufacturing, and Supply Chains President Trump’s latest threat to impose tariffs reaching 250% on pharmaceutical imports represents
Key Takeaways: Neurodegenerative diseases like Alzheimer’s, Parkinson’s, and ALS remain critical unmet needs in medicine. Biotech innovations, from gene therapies to biomarkers, are paving the
Key Takeaways: CRISPR revolutionized genome editing, but new technologies are pushing the boundaries even further. Base editing, prime editing, and epigenome editing offer improved precision
Quick Summary •FDA Clearance: LumiThera’s Valeda system becomes the first FDA-approved treatment for dry age-related macular degeneration (AMD). •Technology: Utilizes photobiomodulation (PBM) therapy to stimulate